Trading Signals: AZN Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Oct. 27, 2023)(AstraZeneca PLC)
| AZN latest price $24.7900 (0.04%) ($24.5100 - $24.8000) on Wed. Nov. 10, 2010. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.09% (three month average) | | RSI | 14 | | Latest Price | $24.7900(0.04%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | AZN declines -0.3% a day on average for past five trading days. | | Weekly Trend | AZN declines -1.9% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support AZN advance at 0% a week (0% probability)
EWG(46%) SPY(46%) EWI(42%) XLP(42%) EEM(41%) | | Factors Impacting AZN price | AZN will decline at least -0.545% in a week (0% probabilities).
TLT(-15%) TIP(-2%) SHY(0%) IGOV(5%) GLD(6%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.545% (StdDev 1.09%) | | Hourly BBV | 0 () | | Intraday Trend | 0.2% | | | | | |
|
| 1 - 5 Day Possible Target | $20.11(-18.88%) | | Resistance Level | $25.56 | | 5 Day Moving Average | $24.9(-0.44%) | | 10 Day Moving Average | $25.01(-0.88%) | | 20 Day Moving Average | $25.56(-3.01%) | | To recent high | -7.3% | | To recent low | 0.3% | | Market Cap | $65.049b | | | | | | |
AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.July 16, 2020 The company was given $1B from the U.S. Biomedical Advanced Research and Development Authority back in late May to supply 400 million doses of the vaccine to the United States. On Wednesday the shares of AstraZeneca were up over 5% after British media reports said that the results of the phase 1 tests were promising. These reports will be published in the Lance medical journal on Monday July 20. |